Kuangli Bio-Tech Holdings Past Earnings Performance
Past criteria checks 0/6
Kuangli Bio-Tech Holdings's earnings have been declining at an average annual rate of -48.2%, while the Electronic industry saw earnings growing at 0.4% annually. Revenues have been growing at an average rate of 12.5% per year.
How Kuangli Bio-Tech Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
TWSE:6431 Revenue, expenses and earnings (TWD Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
353
-195
189
33
31 Dec 25
377
-193
195
33
30 Sep 25
387
-193
187
35
30 Jun 25
425
-182
188
36
31 Mar 25
429
-173
193
33
31 Dec 24
381
-173
181
32
30 Sep 24
333
-148
169
32
30 Jun 24
285
-150
165
32
31 Mar 24
300
-114
152
32
31 Dec 23
293
-104
149
31
30 Sep 23
325
-78
140
31
30 Jun 23
380
-50
124
32
31 Mar 23
337
-66
121
33
31 Dec 22
342
-68
125
32
30 Sep 22
386
-64
138
30
30 Jun 22
402
-64
131
24
31 Mar 22
418
21
121
18
31 Dec 21
333
44
87
11
30 Sep 21
155
69
47
3
30 Jun 21
63
44
51
1
31 Mar 21
51
-35
48
0
31 Dec 20
87
-42
50
1
30 Sep 20
333
-79
62
5
30 Jun 20
413
-34
58
6
31 Mar 20
431
-26
51
8
31 Dec 19
425
-28
47
8
30 Sep 19
228
-21
40
7
30 Jun 19
143
-17
35
7
31 Mar 19
110
-4
32
6
31 Dec 18
100
-19
32
6
30 Sep 18
100
-74
34
6
30 Jun 18
88
-128
32
6
31 Mar 18
93
-157
32
6
31 Dec 17
107
-159
33
6
30 Sep 17
138
-187
33
7
30 Jun 17
159
-197
45
7
31 Mar 17
183
-265
50
7
31 Dec 16
211
-271
54
8
30 Sep 16
252
-295
86
9
30 Jun 16
310
-263
83
11
31 Mar 16
377
-212
81
12
31 Dec 15
417
-208
84
14
30 Sep 15
429
-111
59
13
30 Jun 15
576
-91
70
11
Quality Earnings: 6431 is currently unprofitable.
Growing Profit Margin: 6431 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 6431 is unprofitable, and losses have increased over the past 5 years at a rate of 48.2% per year.
Accelerating Growth: Unable to compare 6431's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 6431 is unprofitable, making it difficult to compare its past year earnings growth to the Electronic industry (-3.3%).
Return on Equity
High ROE: 6431 has a negative Return on Equity (-34.96%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/06/12 21:41
End of Day Share Price
2026/06/12 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Kuangli Bio-Tech Holdings Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.